Removing heart valve growths in right-side heart infections
Part of Heart & circulation clinical trials.
This trial tests a procedure that uses a device to remove infected growths (vegetations) from the right side of the heart. It aims to reduce the risk of these growths breaking off and causing problems like blood infections or blockages.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed infection of the heart's inner lining (infective endocarditis).
- You must have bacteria in your blood with a heart valve growth (vegetation) larger than 1 centimeter, confirmed by an echocardiogram.
- You must be well enough for a heart procedure (no other terminal illness).
- You must not have had a stroke in the last 3 months, have a bleeding disorder, or have a fungal heart infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health data from people who had a procedure called AngioVac, which uses a suction tube to remove blood clots or infected heart valve tissue. It is a registry study, so it does not involve a new treatment; instead, it reviews medical records from past procedures to learn more about safety and effectiveness.
This study tests a new less-invasive heart valve (VenusP-Valve) for people whose own pulmonary valve is leaking severely. If you qualify, you could get the new valve without open-heart surgery.
This trial tests whether a treatment without rifampin works as well as one with rifampin for a type of heart valve infection caused by staph bacteria. It aims to find a simpler and safer option for patients with an infected artificial heart valve.
This study tests whether a new type of heart valve made from your own tissue (an “autologous” valve) can be placed through a catheter safely in adults with leaking and pressure-related problems in the lung heart valve area. If it works well, it could offer a safer option for people who need treatment for pulmonary valve problems.
This trial measures how your body handles certain intravenous antibiotics used for endocarditis, an infection of the heart valves. It may help doctors understand the best antibiotic dosing for people with valve infections.
This study tests an early, first-use version of a new pulmonary valve device for children whose own valve is not working well. It may help improve blood flow from the heart to the lungs and aims to learn how safe and effective the valve is over time.
Hear when a new Infective Endocarditis (IE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.